Study of the Increase in ICU Beds Capacity During COVID-19 Pandemic in France
NCT ID: NCT04420286
Last Updated: 2025-12-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
9860 participants
OBSERVATIONAL
2020-05-06
2020-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
French Multicentre Observational Study on SARS-Cov-2 Infections (COVID-19) ICU Management Study
NCT04340466
COVID-19 Critically Ill Patients' Evolution After Medical Transport by Train From Paris Intensive Care Units to West of France Intensive Care Units
NCT04433325
Ventilation Associated Pneumonia and Covid-19
NCT05089968
NOSOcomial COVID-19 in ICU (NOSOCOVID)
NCT04659356
Dissemination of SARS-COV-2 (COVID-19) in the Environment of Infected Patients Admitted to Intensive Care Unit
NCT04355481
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
For preventing the overwhelming of ICU beds capacity, national and regional Health-Care institutions (then French Health minister, every Regional Health) decided to optimize the Intensive Care Unit beds availability by opening new ICU beds in institutions with and without prior ICU.
Daily ICU beds availability was assessed in each institution, and at the regional level to organize potential patient transfers across regional and national hospital. Moreover, an extraordinary mobilization and joint efforts of medical, paramedical and administrative staff allowed getting the caregivers for managing the most severe patients in each ICU. All physicians who could manage ICU patients were involved in this crisis. In this context, anesthesiologists (who have gotten an ICU education during their studies) were involved, as the surgical activity has been reduced to the vital procedures. This overall organization permitted the admission of more patients than the initial maximum national capacity of ICU beds.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Hospital having ICU beds
Hospital having ICU beds during COVID-19 outbreak in France
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire de Nīmes
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU de Nîmes, Hôpital Universitaire Carémeau
Nîmes, , France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Lefrant JY, Fischer MO, Potier H, Degryse C, Jaber S, Muller L, Pottecher J, Charboneau H, Meaudre E, Lanot P, Bruckert V, Plaud B, Dureuil B, Samain E, Bouaziz H, Ecoffey C, Capdevila X; French ICU study investigators group. A national healthcare response to intensive care bed requirements during the COVID-19 outbreak in France. Anaesth Crit Care Pain Med. 2020 Dec;39(6):709-715. doi: 10.1016/j.accpm.2020.09.007. Epub 2020 Oct 5.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
30RC20_0117
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.